A targeted proteomics approach to the identification of peptides modified by reactive metabolites

Chemical Research in Toxicology

Volumn 22, Issue 5, 2009, Pages 853-862

  Tzouros, Manuel ^a   Pähler, Axel ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO PYRIMIDINE; CARBON 14; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN MODIFICATION; PROTEOMICS; RADIOACTIVITY;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ISOTOPE LABELING; MICROSOMES, LIVER; PEPTIDES; PROTEOMICS; PYRIMIDINES; RATS; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 67649908960     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx800426x     Document Type: Article

References (50)

1. Kalgutkar, A. S., Obach, R. S., and Maurer, T. S. (2007) Mechanism-based inactivation of cytochrome P450 enzymes: Chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions. Curr. Drug Metab. 8, 407-447.
2. Uetrecht, J. (2007) Idiosyncratic drug reactions: current understanding. Annu. Rev. Pharmacol. Toxicol. 47, 513-539.
3. Liebler, D. C., and Guengerich, F. P. (2005) Elucidating mechanisms of drug-induced toxicity. Nat. Rev. Drug Discovery 4, 410-420.
4. Park, B. K., Naisbitt, D. J., Gordon, S. F., Kitteringham, N. R., and Pirmohamed, M. (2001) Metabolic activation in drug allergies. Toxicology 158, 11-23.
5. Liebler, D. C. (2006) The poisons within: Application of toxicity mechanisms to fundamental disease processes. Chem. Res. Toxicol. 19, 610-613.
6. Zhou, S., Chan, E., Duan, W., Huang, M., and Chen, Y. Z. (2005) Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab. Rev. 37, 41-213.
7. Kumar, S., Kassahun, K., Tschirret-Guth, R. A., Mitra, K., and Baillie, T. A. (2008) Minimizing metabolic activation during pharmaceutical lead optimization: Progress, knowledge gaps and future directions. Curr. Opin. Drug Discovery Dev. 11, 43-52.
8. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16.
9. Baillie, T. A., and Davis, M. R. (1993) Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom. 22, 319-325.
10. Dieckhaus, C. M., Fernandez-Metzler, C. L., King, R., Krolikowski, P. H., and Baillie, T. A. (2005) Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem. Res. Toxicol. 18, 630-638.
11. Wen, B., Ma, L., Nelson, S. D., and Zhu, M. (2008) High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry. Anal. Chem. 80, 1788-1799.
12. Aebersold, R., and Mann, M. (2003) Mass spectrometry-based proteomics. Nature 422, 198-207.
13. Gygi, S. P., and Aebersold, R. (2000) Mass spectrometry and proteomics. Curr. Opin. Chem. Biol. 4, 489-494.
14. Steen, H., and Mann, M. (2004) The ABC's (and XYZ's) of peptide sequencing. Nat. Rev. Mol. Cell Biol. 5, 699-711.
15. Liebler, D. C. (2008) Protein damage by reactive electrophiles: targets and consequences. Chem. Res. Toxicol. 21, 117-128.
16. Zhou, S. (2003) Separation and detection methods for covalent drugprotein adducts. J. Chromatogr. B 797, 63-90.
17. Qiu, Y., Benet, L. Z., and Burlingame, A. L. (1998) Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J. Biol. Chem. 273, 17940-17953.
18. He, K., Falick, A. M., Chen, B., Nilsson, F., and Correia, M. A. (1996) Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital. Chem. Res. Toxicol. 9, 614-622.
19. Koenigs, L. L., Peter, R. M., Hunter, A. P., Haining, R. L., Rettie, A. E., Friedberg, T., Pritchard, M. P., Shou, M., Rushmore, T. H., and Trager, W. F. (1999) Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9. Biochemistry 38, 2312-2319.
20. Lightning, L. K., Jones, J. P., Friedberg, T., Pritchard, M. P., Shou, M., Rushmore, T. H., and Trager, W. F. (2000) Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394. Biochemistry 39, 4276-4287.
21. Kent, U. M., Lin, H. L., Mills, D. E., Regal, K. A., and Hollenberg, P. F. (2006) Identification of 17-R-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6. Chem. Res. Toxicol. 19, 279-287.
22. Baer, B. R., Wienkers, L. C., and Rock, D. A. (2007) Time-dependent inactivation of P450 3A4 by raloxifene: Identification of Cys239 as the site of apoprotein alkylation. Chem. Res. Toxicol. 20, 954-964.
23. Yukinaga, H., Takami, T., Shioyama, S. H., Tozuka, Z., Masumoto, H., Okazaki, O., and Sudo, K. (2007) Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-Fourier transform mass spectrometry. Chem. Res. Toxicol. 20, 1373-1378.
24. Kent, U. M., Sridar, C., Spahlinger, G., and Hollenberg, P. F. (2008) Modification of serine 360 by a reactive intermediate of 17-α- ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6. Chem. Res. Toxicol. 21, 1956-1963.
25. Shin, N. Y., Liu, Q., Stamer, S. L., and Liebler, D. C. (2007) Protein targets of reactive electrophiles in human liver microsomes. Chem. Res. Toxicol. 20, 859-867.
26. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micropurification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906.
27. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S., and Mann, M. (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4, 2010-2021.
28. Olsen, J. V., Macek, B., Lange, O., Makarov, A., Horning, S., and Mann, M. (2007) Higher-energy C-trap dissociation for peptide modification analysis. Nat. Methods 4, 709-712.
29. Rice, P., Longden, I., and Bleasby, A. (2000) EMBOSS: The european molecular biology open software suite. Trends Genet. 16, 276-277.
30. Fontana, E. , Bona, V., Hartung, T., Fowler, S., Norcross, R., Riemer, C., and Poli, S. M. In A New in Vitro Approach to Detect Cytochrome P450 Time Dependent Inhibition in Early Drug Discovery: A Case Study, Abstracts of the 2004 EUFEPS Meeting, Brussels, Belgium, October 17-20, 2004.
31. Fontana, E., Dansette, P. M., and Poli, S. M. (2005) Cytochrome P450 enzymes mechanism based inhibitors: Common sub-structures and reactivity. Curr. Drug Metab. 6, 413-454.
32. Ravindranath, V., Burka, L. T., and Boyd, M. R. (1984) Reactive metabolites from the bioactivation of toxic methylfurans. Science 224, 884-886.
33. Thomassen, D., Knebel, N., Slattery, J. T., McClanahan, R. H., and Nelson, S. D. (1992) Reactive intermediates in the oxidation of menthofuran by cytochromes P-450. Chem. Res. Toxicol. 5, 123-130.
34. Törnqvist, M., Fred, C., Haglund, J., Helleberg, H., Paulsson, B., and Rydberg, P. (2002) Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J. Chromatogr. B 778, 279-308.
35. Galeva, N., and Altermann, M. (2002) Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins. Proteomics 2, 713-722.
36. Washburn, M. P., Wolters, D., and Yates, J. R., 3rd (2001) Largescale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247.
37. Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J., and Gygi, S. P. (2003) Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: The yeast proteome. J. Proteome Res. 2, 43-50.
38. Ma, S., and Subramanian, R. (2006) Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 41, 1121-1139.
39. Nisar, S., Lane, C. S., Wilderspin, A. F., Welham, K. J., Griffiths, W. J., and Patterson, L. H. (2004) A proteomic approach to the identification of cytochrome P450 isoforms in male and female rat liver by nanoscale liquid chromatography-electrospray ionizationtandem mass spectrometry. Drug Metab. Dispos. 32, 382-386.
40. Wang, Y., Al-Gazzar, A., Seibert, C., Sharif, A., Lane, C., and Griffiths, W. J. (2006) Proteomic analysis of cytochromes P450: a mass spectrometry approach. Biochem. Soc. Trans. 34, 1246-1251.
41. Hanzlik, R. P., Koen, Y. M., Theertham, B., Dong, Y., and Fang, J. (2007) The reactive metabolite target protein database (TPDB)-A web-accessible resource. BMC Bioinf. 8, 95.
42. Shen, S., Hargus, S. J., Martin, B. M., and Pohl, L. R. (1997) Cytochrome P4502C11 is a target of diclofenac covalent binding in rats. Chem. Res. Toxicol. 10, 420-423.
43. Svensson, R., Rinaldi, R., Swedmark, S., and Morgenstern, R. (2000) Reactivity of cysteine-49 and its influence on the activation of microsomal glutathione transferase 1: Evidence for subunit interaction. Biochemistry 39, 15144-15149.
44. Busenlehner, L. S., Codreanu, S. G., Holm, P. J., Bhakat, P., Hebert, H., Morgenstern, R., and Armstrong, R. N. (2004) Stress sensor triggers conformational response of the integral membrane protein microsomal glutathione transferase 1. Biochemistry 43, 11145-11152.
45. Dalvie, D. K., Kalgutkar, A. S., Khojasteh-Bakht, S. C., Obach, R. S., and O'Donnell, J. P. (2002) Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem. Res. Toxicol. 15, 269-299.
46. Alvarez-Sanchez, R., Montavon, F., Hartung, T., and Pähler, A. (2006) Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. Chem. Res. Toxicol. 19, 1106-1116.
47. Kalgutkar, A. S., Vaz, A. D., Lame, M. E., Henne, K. R., Soglia, J., Zhao, S. X., Abramov, Y. A., Lombardo, F., Collin, C., Hendsch, Z. S., and Hop, C. E. (2005) Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4. Drug Metab. Dispos. 33, 243-253.
48. Kalgutkar, A. S., Henne, K. R., Lame, M. E., Vaz, A. D., Collin, C., Soglia, J. R., Zhao, S. X., and Hop, C. E. (2005) Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinoneimine and epoxide intermediates in human liver microsomes and recombinant P4503A4. Chem.-Biol. Interact. 155, 10-20.
49. Pähler, A., and Funk, C. (2008) Chapter 2. Drug-induced hepatotoxicity: Learning from recent cases of drug attrition. In Advances in Molecular Toxicology (Fishbein, J. C., Ed.) pp 25-56, Elsevier, Amsterdam.
50. Obach, R. S., Kalgutkar, A. S., Soglia, J. R., and Zhao, S. X. (2008) Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. Chem. Res. Toxicol. 21, 1814-1822.